Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature

1 Feb 1999

Abstract excerpt

A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-occlusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malformations. A literature review, including this case, suggests that the risk of hydroxyurea exposure during in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Iron Metabolism and Disorders
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9929109
DOI: 10.1002/(sici)1096-8652(199902)60:2<148::aid-ajh12>3.0.co;2-i

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literaturePMID 9929109Read ↗

Pregnancy outcomes with hydroxyurea use in women with sickle cell diseaseSemantic proximity Read ↗

Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gapsSemantic proximity Read ↗

Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolismSemantic proximity Read ↗

Successful Use of Hydroxyurea in β-Thalassemia MajorSemantic proximity Read ↗

A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemicSemantic proximity Read ↗

Barriers to the use of hydroxyurea in the management of sickle cell disease in NigeriaSemantic proximity Read ↗

Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaSemantic proximity Read ↗

Hydroxyurea in sickle cell disease—A study of clinico-pharmacological efficacy in the Indian haplotypeSemantic proximity Read ↗

DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyureaSemantic proximity Read ↗

Provider Barriers to Hydroxyurea Use in Adults with Sickle Cell Disease: A Survey of the Sickle Cell Disease Adult Provider NetworkSemantic proximity Read ↗

Use of hydroxyurea in children with sickle cell disease: what comes next?Semantic proximity Read ↗

Management of Sickle Cell Disease in PregnancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.